Pharmaceutical companies face cost-containment pressure to maintain an innovative pipeline. Our mission is to provide drug discovery resources that are led and managed by Singapore and US-based scientific project leadership and execution with Indian team. This would lead to transform the efficiency of drug discovery research with cost effective manner. The aim has always been to blend scientific expertise and excellence with a passion for drug discovery IgY IMMUNOLOGIX strategic approach will create novel chemical compounds to address known protein targets; both where drugs with proof of concept and where there is a gap exists. IgY IMMUNOLOGIX employs a target based approach on specific diseases and applications. We select projects in the translational space with substantive animal or human proof of concept data. We have a diverse portfolio of programs ranging from cancer metastasis, solid tumors and Immunology and inflammatory disorders. IgY IMMUNOLOGIX has developed Platform applicable to drug candidate, generating patentable NCEs addressing physico-chemical and pharmacological properties.
IgY IMMUNOLOGIX team is capable of developing clinical candidate. Our mission is to contribute to the discovery of novel drugs that are safe and effective medicines for the treatment of a wide range of human diseases in the area of oncology and inflammation. IgY IMMUNOLOGIX employs a target based approach instead of focusing on specific diseases and applications. We select projects in the translational space with substantive animal or human proof of concept data. We have a diverse portfolio of programs ranging from resistant and recurrent cancers, solid tumors, multi-drug resistant infections and repurposing of drugs. Additionally, IgY IMMUNOLOGIX has developed a proprietary Drug Modification Platform applicable to almost ANY drug candidate, generating patentable NCEs addressing sub-optimal physico-chemical and pharmacological properties such as poor solubility, absorption, and associated pharmacokinetic parameters.
Our research is driven by applying translational expertise to academic excellence through our collaborators and partners. We understand what it takes to successfully commercialize ground-breaking discoveries into drugs that will change the lives of patients worldwide.